Keyphrases
Type 2 Diabetes Mellitus (T2DM)
100%
Free Fatty Acid Receptors
100%
Insulin
33%
Toxic Effects
16%
Liver
16%
Intestinal Cells
16%
Phase III Clinical Trial
16%
Glucose Concentration
16%
Neurological Disorders
16%
Progress Management
16%
Binding Site
16%
Hypoglycemia
16%
Hepatotoxicity
16%
Drug Discovery
16%
G Protein-coupled Receptor
16%
TAK-875
16%
Pancreatic β-cells
16%
Glucose Metabolism
16%
Metabolic Disorders
16%
Incretin Secretion
16%
Nerve Cells
16%
Targetless
16%
Biochemistry, Genetics and Molecular Biology
Agonist
100%
Free Fatty Acid Receptor 1
100%
Hope
100%
Eicosanoid Receptor
37%
Secretion (Process)
25%
Clinical Trial
12%
Binding Site
12%
Glucose Metabolism
12%
Sensation
12%
G Protein Coupled Receptor
12%
Metabolic Disorder
12%
Incretin
12%
Pharmacology, Toxicology and Pharmaceutical Science
Non Insulin Dependent Diabetes Mellitus
100%
G Protein Coupled Receptor 40
100%
Receptor
50%
Toxicity
16%
Clinical Trial
16%
Neurologic Disease
16%
Binding Site
16%
Hypoglycemia
16%
Hepatotoxicity
16%
Drug Discovery
16%
Metabolic Disorder
16%
G Protein Coupled Receptor
16%
Incretin
16%